Hepatitis B Foundation Plans Externally-Led Patient-Focused Drug Development Meeting for Chronic Hepatitis B in June 2020
November 07, 2019
November 07, 2019
DOYLESTOWN, Pennsylvania, Nov. 7 -- The Hepatitis B Foundation issued the following news release:
The Hepatitis B Foundation is pleased to have been approved by the U.S. Food and Drug Administration (FDA) to host an externally-led Patient-Focused Drug Development (PFDD) meeting on June 9, 2020 that will focus on chronic hepatitis B infection (CHB). This will be a one-day meeting held in Rockville, MD, where patients and key stakeholders will be invited to gather for highly interacti . . .
The Hepatitis B Foundation is pleased to have been approved by the U.S. Food and Drug Administration (FDA) to host an externally-led Patient-Focused Drug Development (PFDD) meeting on June 9, 2020 that will focus on chronic hepatitis B infection (CHB). This will be a one-day meeting held in Rockville, MD, where patients and key stakeholders will be invited to gather for highly interacti . . .